Connect with us

Hi, what are you looking for?

News

Nanobiotix: A Promising Cancer Treatment But A Risky Investment For Now (NASDAQ:NBTX)

Preamble

There is not much coverage of this company on Seeking Alpha, just two articles and the last one was in January 2021. Put simply, Nanobiotix (NASDAQ:NBTX) is not a popular company, with just 541 Seeking Alpha followers expressingTSLA

Fast Graph

Fast Graph

NBTX IR Website

NBTX IR Website

Slide from 2020 Webinar. Left shows tumor cell. Right shows tumor cell penetrated by NBTXR3

Slide from 2020 Webinar. Left shows tumor cell. Right shows tumor cell penetrated by NBTXR3

From 2020 Webinar by CEO

From 2020 Webinar by CEO

Phase 2 Success Rate

Phase 2 Success Rate

Clinical Trial Success Rate

Clinical Trial Success Rate

From 2020 Webinar

From 2020 Webinar – Ongoing Trials

From 2020 Webinar

From 2020 Webinar on Completed Studies

https://www.nanobiotix.com/evaluating-the-broad-potential-of-nbtxr3/

NBTX Website Shows Pipeline

Fast Graph

Fast Graph

Wall Street Analysts Strong Buy Calls on Seeking Alpha

Wall Street Analysts’ Strong Buy Calls on Seeking Alpha

Wall Street Analysts Price Target on Seeking Alpha

Wall Street Analysts Price Target on Seeking Alpha

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube